View Archive »
ABOUT THE VOLUME
As we enter 2026, the scientific and publishing communities are facing a lot of challenges. In this environment, our journal aims to provide a platform for the open exchange of scientific ideas, including those that address important and, at times, controversial topics. We welcome diverse opinions and encourage authors to express and share their views —agree or disagree, your views are welcome. Authors of accepted papers will benefit from active post-publication promotion and opportunities to participate in round-table discussions and video interviews about their research.
Table of Contents
COVID vaccination and post-infection cancer signals: Evaluating patterns and potential biological mechanisms
COVID vaccination and post-infection cancer signals: Evaluating patterns and potential biological mechanisms |
|
https://doi.org/10.18632/oncotarget.28824
Charlotte Kuperwasser,
and Wafik S. El-Deiry
|
| 1-29 |
Hypothesis: HPV E6 and COVID spike proteins cooperate in targeting tumor suppression by p53
Hypothesis: HPV E6 and COVID spike proteins cooperate in targeting tumor suppression by p53 |
|
https://doi.org/10.18632/oncotarget.28823
Wafik S. El-Deiry
|
| 30-33 |
Exploring the potential link between mRNA COVID-19 vaccinations and cancer: A case report with a review of haematopoietic malignancies with insights into pathogenic mechanisms
Exploring the potential link between mRNA COVID-19 vaccinations and cancer: A case report with a review of haematopoietic malignancies with insights into pathogenic mechanisms |
|
https://doi.org/10.18632/oncotarget.28827
Patrizia Gentilini,
Janci C. Lindsay,
Nafuko Konishi,
Masanori Fukushima,
and Panagis Polykretis
|
| 34-49 |
Censorship in science: How publishing decisions could have shaped the perceived “general consensus” on COVID-19 vaccine safety and efficacy
Censorship in science: How publishing decisions could have shaped the perceived “general consensus” on COVID-19 vaccine safety and efficacy |
|
https://doi.org/10.18632/oncotarget.28829
Panagis Polykretis,
Janci C. Lindsay,
Patrizia Gentilini,
Nafuko Konishi,
and Masanori Fukushima
|
| 50-53 |
CAR-T therapy: Trailblazing CAR(ing) in cancer treatment
CAR-T therapy: Trailblazing CAR(ing) in cancer treatment |
|
https://doi.org/10.18632/oncotarget.28836
Uzma Saqib,
Monika Pandey,
and Krishnan Hajela
|
| 54-56 |
Correction: Anti-correlation of KLRG1 and PD-1 expression in human tumor CD8 T cells
Correction: Anti-correlation of KLRG1 and PD-1 expression in human tumor CD8 T cells |
|
https://doi.org/10.18632/oncotarget.28846
Steven A. Greenberg
|
| 57-58 |
CREB5 regulates stem cell-like transcriptional programs to enhance tumor progression in prostate cancer
CREB5 regulates stem cell-like transcriptional programs to enhance tumor progression in prostate cancer |
|
https://doi.org/10.18632/oncotarget.28826
Allison Makovec,
John T. Phoenix,
Hannah E. Bergom,
Ella Boytim,
Ava P. Gustafson,
Aiden Deacon,
Sydney Tape,
Atef Ali,
Megan Ludwig,
Samuel P. Pitzen,
David Moline,
Camden Richter,
Hudson Longie,
Mei-Chi Su,
Sampreeti Jena,
Pornlada Likasitwatanakul,
Justin M. Drake,
R. Stephanie Huang,
William C. Hahn,
Jonathan P. Rennhack,
Scott M. Dehm,
Steven Kregel,
Emmanuel S. Antonarakis,
and Justin Hwang
|
| 59-73 |
